Dianthus Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €158.99M +337.0% -€131.13M -17.9% -82.5% +3.6 pp N/A N/A
    (estimated) €36.38M +1,428.7% -€159.69M -3.1% -439.0% +65 pp N/A N/A
    (estimated) €2.38M +20.3% -€164.83M +23.3% -6,926.5% -1.7 pp N/A N/A
    (estimated) €1.98M -4.1% -€133.67M +22.5% -6,754.7% -15 pp N/A N/A
    (estimated) €2.06M -61.2% -€109.10M +50.5% -5,285.5% -39 pp N/A N/A
    €5.32M +120.6% -€72.47M +95.1% -1,362.8% +1.8 pp -€66.59M +112.4% -1,252.2% +0.48 pp
    €2.41M -56.0% -€37.15M +53.0% -1,541.2% -11 pp -€31.35M +27.0% -1,300.5% -8.5 pp
    €5.47M +334.8% -€24.29M +117.2% -443.8% +4.4 pp -€24.68M +193.1% -450.8% +2.2 pp
    €1.26M +∞% -€11.18M -82.5% -888.1% -8.9 pp -€8.42M -84.5% -668.8% -6.7 pp
    €0.00 +NaN% -€63.92M -2.4% N/A -€54.27M +17.7% N/A
    €0.00 +NaN% -€65.48M +33.5% N/A -€46.10M +58.0% N/A
    €0.00 +NaN% -€49.06M +62.1% N/A -€29.18M +70.5% N/A
    €0.00 +NaN% -€30.27M +276.3% N/A -€17.11M +214.0% N/A
    €0.00 -€8.04M N/A -€5.45M N/A

    Notifications